Urovant Sciences
Why Robinhood?
You can watch UROV and buy or sell other stocks, ETFs, and their options commission-free!About UROV
Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902.
UROV Key Statistics
Stock Snapshot
As of today, Urovant Sciences(UROV) shares are valued at $16.24. The company's market cap stands at 531.75M, with a P/E ratio of -3.09.
Urovant Sciences(UROV) stock opened on 2026-04-04 at —. The price climbed to — and dipped to —.
The Urovant Sciences(UROV)'s current trading volume is 0, compared to an average daily volume of 222.74K.
In the last year, Urovant Sciences(UROV) shares hit a 52-week high of $16.26 and a 52-week low of $7.15.
In the last year, Urovant Sciences(UROV) shares hit a 52-week high of $16.26 and a 52-week low of $7.15.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.